Clinical Trials
I-Mab receives China NMPA clearance to begin phase 1...
I-Mab, a clinical stage biopharmaceutical company, announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has cleared the...
Clinical Trials
RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron’s REGN-COV2...
Regeneron Pharmaceuticals, Inc. and the University of Oxford today announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world's largest randomized clinical trials...
Clinical Trials
Sorrento Receives US FDA Clearance to Proceed With Phase...
Sorrento Therapeutics, Inc. announced that it received a study may proceed letter from the FDA for its phase 1 clinical trial for COVI-GUARD (STI-1499) in...
Clinical Trials
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine...
Pfizer Inc. and BioNTech SE announced that they have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment of...
Clinical Trials
Takeda Announces Results from Phase 3 Clinical Trial Evaluating...
Takeda Pharmaceutical Company Limited announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition of NINLAROâ„¢ (ixazomib) to lenalidomide and dexamethasone versus lenalidomide and...
Clinical Trials
Phesi data show clinical trial suspensions continue to rise...
Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites unable to bounce back following...
Clinical Trials
Merck announces positive results phase 3 trials of gefapixant...
Merck, known as MSD outside the United States and Canada, has announced the results from two pivotal phase 3 trials (COUGH-1 and COUGH-2) evaluating the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.